Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Suzanne M Bleker"'
Autor:
Ingrid M. Bistervels, Hanke M.G. Wiegers, Fionnuala Ní Áinle, Suzanne M. Bleker, Céline Chauleur, Jennifer Donnelly, Anne F. Jacobsen, Marc A. Rodger, Maria T. DeSancho, Peter Verhamme, Anette T. Hansen, Roman G. Shmakov, Wessel Ganzevoort, Andrea Buchmüller, Saskia Middeldorp
Publikováno v:
Journal of Thrombosis and Haemostasis, 21, 57-67
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Item does not contain fulltext BACKGROUND: Peripartum management of women using low-molecular-weight heparin (LMWH) varies widely. Minimum time intervals are required between LMWH injection and neuraxial procedure, and they differ by dose. OBJECTIVES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3654d189dac1bc9406534275cd70541
http://hdl.handle.net/2066/290874
http://hdl.handle.net/2066/290874
Autor:
Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis
Publikováno v:
The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Item does not contain fulltext BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
Autor:
Nick van Es, Marcello Di Nisio, Gabriela Cesarman, Ankie Kleinjan, Hans-Martin Otten, Isabelle Mahé, Ineke T. Wilts, Desirée C. Twint, Ettore Porreca, Oscar Arrieta, Alain Stépanian, Kirsten Smit, Michele De Tursi, Suzanne M. Bleker, Patrick M. Bossuyt, Rienk Nieuwland, Pieter W. Kamphuisen, Harry R. Büller
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer patients at high risk of venous thromboembolism have been proposed, but their
Externí odkaz:
https://doaj.org/article/77d002a752324e66b38d01ca68793735
Autor:
I.T. Wilts, Kirsten F. Smit, Pieter W. Kamphuisen, Michele De Tursi, Ettore Porreca, Harry R. Büller, Rienk Nieuwland, Hans-Martin Otten, Alain Stepanian, Patrick M.M. Bossuyt, Desirée C. Twint, Gabriela Cesarman, Suzanne M. Bleker, Nick van Es, Marcello Di Nisio, Isabelle Mahé, A. Kleinjan, Oscar Arrieta
Publikováno v:
Haematologica, 102(9), 1494-1501. Ferrata Storti Foundation
Haematologica, 102(9), 1494-1501. FERRATA STORTI FOUNDATION
Haematologica
Haematologica, 102(9), 1494-1501. FERRATA STORTI FOUNDATION
Haematologica
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer patients at high risk of venous thromboembolism have been proposed, but their
Autor:
Giuseppe Camporese, Jan Beyer-Westendorf, N. van Es, Marc Philip Righini, Anita Aggarwal, A. Kleinjan, M. Di Nisio, Suzanne M. Bleker, H.R. Büller, Peter Verhamme, Patrick M.M. Bossuyt
Publikováno v:
Journal of Thrombosis and Haemostasis, Vol. 15, No 1 (2017) pp. 66-73
Journal of thrombosis and haemostasis, 15(1), 66-73. Wiley-Blackwell
Journal of thrombosis and haemostasis, 15(1), 66-73. Wiley-Blackwell
Essentials The Constans score and D-dimer can rule out upper extremity deep vein thrombosis without imaging. We evaluated the performance of an extended Constans score and an age-adjusted D-dimer threshold. The extended Constans score did not increas
Autor:
Saskia Middeldorp, Suzanne M. Bleker, Madelyn Curto, Gary E. Raskob, Alexander T. Cohen, Alexander Gallus, Melanie Sisson, Jeffrey I. Weitz, Giancarlo Agnelli, Harry R. Büller
Publikováno v:
Thrombosis and Haemostasis. 116:1159-1164
SummaryApixaban, a direct acting oral anticoagulant (DOAC), was found to be non-inferior to and safer as enoxaparin followed by warfarin for treatment of venous thromboembolism (VTE) in the AMPLIFY trial. Information is needed on how bleeding events
Autor:
K. Kaasjager, S van Wissen, Giuseppe Camporese, Peter Marschang, Marc Philip Righini, H. M. Otten, Anita Aggarwal, Benilde Cosmi, Suzanne M. Bleker, Jan Beyer-Westendorf, Ettore Porreca, Peter Verhamme, M. Di Nisio, Karina Meijer, A. Kleinjan, T Gary, Teresa Lerede, Angelo Ghirarduzzi, Harry R. Büller, N. van Es, Pieter W. Kamphuisen
Publikováno v:
Journal of Thrombosis and Haemostasis, Vol. 14, No 5 (2016) pp. 973-981
Journal of thrombosis and haemostasis, 14(5), 973-981. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 14(5), 973-981. Wiley
Journal of thrombosis and haemostasis, 14(5), 973-981. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 14(5), 973-981. Wiley
Essentials Few data exist on outcome of upper extremity deep and superficial vein thrombosis (UEDVT and UESVT). We followed 102 and 55 patients with UEDVT or UESVT, respectively, for a median of 3.5 years. Risk of recurrent venous thromboembolism was
Autor:
Luuk van Gils, A. Kleinjan, Joost G. Daams, Nick van Es, Marcello Di Nisio, Suzanne M. Bleker, Harry R. Büller
Publikováno v:
Thrombosis research, 140(Suppl. 1), S81-S88. Elsevier Limited
Background The incidence of upper extremity deep vein thrombosis (UEDVT) is increasing. Information on the clinical course of UEDVT is scarce, especially in cancer patients. Aim To summarize the clinical evidence regarding long-term clinical outcomes
Autor:
Giuseppe Camporese, Jan Beyer-Westendorf, Suzanne M. Bleker, A. Kleinjan, Patrick M.M. Bossuyt, Pieter W. Kamphuisen, Nick van Es, Harry R. Büller, Marcello Di Nisio
Publikováno v:
Thrombosis research, 148, 59-62. Elsevier Limited
Introduction In a management study, a diagnostic algorithm consisting of a clinical decision rule, D-dimer, and ultrasonography was shown to safely exclude upper extremity deep vein thrombosis (UEDVT). Efficiency may be lower in high-risk subgroups:
Autor:
Suzanne M, Bleker, Marjolein P A, Brekelmans, Elise S, Eerenberg, Alexander T, Cohen, Saskia, Middeldorp, Gary, Raskob, Harry R, Büller
Publikováno v:
Thrombosis and haemostasis. 117(10)
Factor Xa (fXa)-inhibitors are as effective and safer than vitamin-K-antagonists (VKA) in the treatment of venous thromboembolism (VTE). We previously classified the severity of clinical presentation and course of all major bleeding events from the E